SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers

Disclosure: D. Toro-Tobon: None. J.C. Morris: None. C. Hilger: None. C.S. Peskey: None. D.M. Jolanta: None. M.M. Ryder: None. Objective: Patients with metastatic differentiated thyroid cancer (DTC) that are radioactive iodine (RAI) refractory (RAIR) have a poor prognosis. Redifferentiation therapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Toro-Tobon, David, Morris, John C, Hilger, Crystal, Peskey, Candy S, Jolanta, Durski M, Ryder, Mabel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553619/
http://dx.doi.org/10.1210/jendso/bvad114.1992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553619/
http://dx.doi.org/10.1210/jendso/bvad114.1992

Ejemplares similares